LGC’s ultra-high throughput Nexar™ technology provides significant PCR testing capacity at Rosalind Franklin Laboratory

News - Ultra-high throughput technology enables large-scale PCR testing in reposnse to global pandemic

13 July 2021

LGC's "incredibly critical" ultra-high-throughput CoVid workflow spotlighted in GenomeWeb

Blog - Mark Dearden recently spoke with GenomeWeb to discuss CoVid workflow and much more besides

30 September 2021

LGC instruments support important milestones

Blog - LGC’s validated technology provides gold-standard sensitivity and specificity based on clinical data, as well as material cost and time savings.

25 October 2021

LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

29 October 2021

LGC acquires Rapid Genomics, bolstering its position in the application of NGS for high-throughput genotyping market in AgBio

News - Rapid Genomics is a leading company in genotyping applications via Next-Generation Sequencing

01 April 2022

LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing

27 April 2022

LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

16 September 2022